Wendy Wolfman
University of Toronto
11 Papers
7 Citations
Wendy Wolfman is an academic researcher from University of Toronto. The author has contributed to research in topics: Medicine & Cancer. The author has an hindex of 5, co-authored 11 publications.
Chat about Author
Papers
O-RADS US Risk Stratification and Management System: A Consensus Guideline from the ACR Ovarian-Adnexal Reporting and Data System Committee
Rochelle F. Andreotti,Dirk Timmerman,Lori M. Strachowski,Wouter Froyman,Beryl R. Benacerraf,Genevieve L. Bennett,Tom Bourne,Douglas L. Brown,Beverly G. Coleman,Mary C. Frates,Steven R. Goldstein,Ulrike M. Hamper,Mindy M. Horrow,Marta Hernanz-Schulman,Caroline Reinhold,Stephen L. Rose,Brad P. Whitcomb,Wendy Wolfman,Phyllis Glanc +18 more
TL;DR: The Ovarian-Adnexal Reporting and Data System (O-RADS) US risk stratification and management system is designed to provide consistent interpretations, to decrease or eliminate ambiguity in US reports resulting in a higher probability of accuracy in assigning risk of malignancy to ovarian and other adnexal masses, and to provide a management recommendation for each risk category.
352
Premature ovarian insufficiency: an International Menopause Society White Paper
Nicholas Panay,Richard A. Anderson,R. E. Nappi,Amanda J. Vincent,Svetlana Vujovic,L. Webber,Wendy Wolfman +6 more
TL;DR: It is hoped that a global task force will be convened in order to formulate a consensus statement across key societies, to accelerate date collection and analysis of a global POI registry, and to facilitate progress in the key defined areas of research.
197
First International Consensus Report on Adnexal Masses: Management Recommendations.
Phyllis Glanc,Beryl R. Benacerraf,Tom Bourne,Douglas L. Brown,Beverly G. Coleman,Christopher P. Crum,Jason Dodge,Deborah Levine,Edward J. Pavlik,Dirk Timmerman,Frederick R. Ueland,Wendy Wolfman,Steven R. Goldstein +12 more
TL;DR: The panel concluded that patients would benefit not only from a more conservative approach to many benign adnexal masses but also from optimization of physician referral patterns to a gynecologic oncologist in cases of suspected ovarian malignancies.
101
A core outcome set for vasomotor symptoms associated with menopause: the COMMA (Core Outcomes in Menopause) global initiative.
Sarah Lensen,David F. Archer,Robin J. Bell,Janet S. Carpenter,Monica Christmas,Susan R. Davis,Karen Giblin,Steven R. Goldstein,Tim Hillard,Myra S. Hunter,Stamatina Iliodromiti,Unnop Jaisamrarn,Hadine Joffe,Sunila Khandelwal,Ludwig Kiesel,Bobae V. Kim,Cornelis B. Lambalk,Mary Ann Lumsden,Pauline M. Maki,Rossella E. Nappi,Nick Panay,Helen Roberts,Jan L. Shifren,James A. Simon,Amanda J. Vincent,Wendy Wolfman,Martha Hickey +26 more
TL;DR: A Core Outcome Set for use in clinical trials of treatments for VMS will better enable research studies to accurately reflect the joint priorities of postmenopausal women, clinicians and researchers, standardize outcome reporting, and facilitate combining and comparing results from different studies, and ultimately improve outcomes for women with bothersome VMS.
34
Factors associated with use of hormone therapy after preventive oophorectomy in BRCA mutation carriers.
Javier César Mejía-Gómez,Jacek Gronwald,Leigha Senter,Beth Y. Karlan,Nadine Tung,Wendy Wolfman,R. Demsky,Ping Sun,Steven A. Narod,Joanne Kotsopoulos +9 more
TL;DR: Clinician and patient awareness may lead to better utilization of HT in women who undergo oophorectomy at an early age to help mitigate the adverse effects associated with surgical menopause.
8